International Journal of Lung Cancer
Издатель: Elsevier · ISSN 3117-504X · 41 статей
- Phase II study of brigatinib for ALK-positive advanced non-small cell lung cancer with untreated brain metastases (LOGIK2201: BRAVES)
- Frequency and safety of pegfilgrastim use in patients with lung cancer treated with combination therapy of cytotoxic chemotherapy and immune checkpoint inhibitors: A CS-lung-003-registry-based prospective observational study
- A multicenter phase Ⅱ study of osimertinib plus infliximab in patients with EGFR-mutated non-small cell lung cancer positive for TP53 gain-of-function mutation who developed resistance to osimertinib (REGAIN trial)
- Impact of platinum-free interval on the efficacy of platinum retreatment for recurrent non-small cell lung cancer after perioperative platinum-based chemotherapy: A multicenter retrospective study
- Clinical characteristics and outcomes of patients with incidentally detected venous thromboembolism versus patients with clinically suspected venous thromboembolism in primary lung cancer: A single-center experience
- The 6-min walk test to assess surgical invasiveness of segmentectomy versus lobectomy for non-small-cell lung cancer: A multicenter prospective study
- Competing mortality risks in radiologically aggressive stage IA1–2 non-small cell lung cancer
- The changing landscape of stage IV lung squamous cell carcinoma: Long-term trends with immune checkpoint inhibitors and contemporary regimens
- Survival after initial non-treatment of registry-identified early-stage lung cancer: outcomes in patients with interstitial lung disease
- Malignant pleural mesothelioma diagnosed with BAP1 tumor predisposition syndrome via comprehensive genomic profiling: A case report
- Difficulty in differentiating lymphoma arising in methotrexate-related immune deficiency/dysregulation from lung cancer: A case report